Here, we studied the role of GRAMD1A in the prognosis, initiation and progression of HCC, we analyzed the correlation between GRAMD1A levels and many clinicopathological features, and examined whether GRAMD1A could function as a prognostic factor for HCC patients. Here, GRAMD1A is linked to hepatocellular carcinoma.